Identification of Five Tumor Antigens for Development and Two Immune Subtypes for Personalized Medicine of mRNA Vaccines in Papillary Renal Cell Carcinoma

Increasing evidence has revealed the promise of mRNA-type cancer vaccines as a new direction for cancer immune treatment in several solid tumors, however, its application in papillary renal cell carcinoma (PRCC) remains unclear. The purpose of this study was to identify potential tumor antigens and...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Jianpei, Yuan, Zhongze, Jiang, Yifen, Mo, Zengnan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9965942/
https://www.ncbi.nlm.nih.gov/pubmed/36836593
http://dx.doi.org/10.3390/jpm13020359

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9965942/
https://www.ncbi.nlm.nih.gov/pubmed/36836593
http://dx.doi.org/10.3390/jpm13020359

Ejemplares similares